Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Internal Medicine
•
Hematology
•
Pediatric Hematology
How would you approach management of bleeding risk and factor VIII replacement in a patient with severe hemophilia A undergoing stem cell transplant?
Answer from: at Academic Institution
Same way as anyone with severe hemophilia: Prophy with QOD factor or weekly hemlibra Extra correction for procedures, trauma, or bleeding
Comments
at Ann & Robert H. Lurie Children’s Hospital of Chicago
Thank you Dr. @Gary Kupfer! Would you have any con...
at Georgetown University Hospital
Good point. I wouldn’t say it is studied...
7770
7773
Sign in or Register to read more
15541
Related Questions
How is your experience with point-of-care INR systems for home monitoring of vitamin K antagonists?
Which classes of medications are reasonable to consider in cases of acute pericarditis in a patient with G6PD deficiency?
Do you screen children with sickle cell disease for silent cerebral infarcts?
Does your evaluation of a young person with spontaneous upper extremity DVT vary as compared to lower extremity DVT?
What subset of sickle cell disease patients are you offering sickle cell disease gene therapy?
What is your target Hgb/Hct for women who are pregnant and have sickle cell disease in whom you are doing scheduled transfusions?
How would you manage a young patient with HL who develops HF (EF < 30%) after 4 cycles of A+AVD who obtained a PET2 CR?
What is your strategy for optimizing hydroxyurea dosage in patients with symptomatic sickle cell disease, particularly for genotypes HbSS and HbS/Beta thal?
What would you recommend for long term management of extensive dural venous sinus thrombosis (CVST) in young females when the only provoking risk factor is combined OCP?
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
Thank you Dr. @Gary Kupfer! Would you have any con...
Good point. I wouldn’t say it is studied...